Platelets: the next-generation ovarian cancer biomarker?
Platelets may carry early warning signs of ovarian cancer in blood, opening a path to catch the disease before symptoms appear.
This review from MD Anderson synthesizes emerging evidence that circulating platelets carry tumor-derived molecular signatures detectable via liquid biopsy, offering a novel diagnostic approach for ovarian cancer. Platelet-based biomarkers may overcome limitations of current late-stage detection methods and CA-125, which lacks sensitivity and specificity.
What the study was
- Study design
- Narrative review
- Population
- Ovarian cancer patients
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Trends in cancer
Why it surfaced
High-impact review journal (Trends Cancer); novel biomarker class for ovarian cancer (high unmet need for early detection); EARLY_CANCER_DETECTION flag applied; elevated to HIGH.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.